Skip to main content

Peer Review reports

From: Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer

Original Submission
9 Sep 2014 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
22 Apr 2015 Editorially accepted
1 May 2015 Article published 10.1186/s12885-015-1350-6

You can find further information about peer review here.

Back to article page